Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07903051
PHASE2

Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery

Sponsor: Beijing Tiantan Hospital

View on ClinicalTrials.gov

Summary

This study tests whether lemborexant can improve perioperative sleep quality in people with brain tumor undergoing surgery. Adults with brain tumor scheduled for surgery may join. Participants will be randomly assigned to take lemborexant or a placebo the night before surgery. Researchers will measure sleep quality, anesthesia recovery, pain, postoperative recovery, and other outcomes.

Official title: Effect of Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

112

Start Date

2026-11-01

Completion Date

2027-12-31

Last Updated

2026-10-29

Healthy Volunteers

No

Interventions

DRUG

Lemborexant 5 mg

Participants will receive a single oral dose of lemborexant 5 mg tablet on the night before brain tumor surgery.

DRUG

placebo

Participants will receive a single oral dose of matching placebo tablet on the night before brain tumor surgery.